Credevo

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Credevo, Health/Medical/ Pharmaceuticals, Singapore.

A global Clinical Trial Organization (CTO) providing comprehensive clinical trial services for pharmaceuticals, biologics, medical devices and healthcare products Credevo provides strategic support for healthcare products including;

- Drugs

- Biologics

- Health Supplements (Nutraceuticals)

- IVD and medical devices

- Cosmetics

In areas of

- Regulatory

- Clinical Development

- Business Development Support

- Licensing (out-/in-)

- Feasibility

02/01/2026

🧪 Are Bioavailability and Bioequivalence Studies Essential for Nutraceuticals?

In today’s evidence-driven wellness market, bioavailability (BA) and bioequivalence (BE) studies are becoming essential to demonstrate that nutraceuticals truly deliver clinical value. Poor absorption, formulation differences, food effects, and individual variability can all significantly impact real-world efficacy.

🔍 The challenge
Many nutraceutical actives show strong in vitro potential but fail to reach meaningful systemic exposure in vivo. Without robust BA/BE data, products risk limited credibility, regulatory hurdles, and weak market differentiation.

✅ The solution
Well-designed BA/BE studies generate reliable pharmacokinetic data, support regulatory acceptance, and strengthen scientific and commercial positioning. With the right expertise, these studies can be executed efficiently without compromising data quality.

At Credevo, we support nutraceutical developers with end-to-end guidance on BA/BE study design, ex*****on, and data interpretation, helping translate science into credible claims and market confidence.

👉 Speak with our experts
https://credevo.com/contact

Read the full guide 👉 https://tinyurl.com/r848car5

01/01/2026

🏥 Rare Disease Clinical Trials in the USA: Turning Complexity into Progress 🧬

With over 7,000 rare diseases and fewer than 10% having FDA-approved treatments, rare disease drug development faces a critical challenge: finding the right clinical trial sites and patients.

💡 The solution? Strategic site selection and regulatory-ready trial planning.

The United States continues to lead rare disease clinical research due to:
🔹 Accelerated FDA review and orphan drug exclusivity
🔹 Tax credits, grants, and user fee waivers
🔹 Advanced site infrastructure and experienced investigators
🔹 Strong patient recruitment and retention capabilities

🌟 Leading U.S. research centers, including Dana-Farber, MD Anderson, Mayo Clinic, Memorial Sloan Kettering, Cedars-Sinai, St. Jude, and OHSU Knight Cancer Institute, are driving innovation for rare disease patients worldwide.

✍️ How Credevo helps
We support rare disease programs through medical writing, site feasibility, and clinical development strategy, helping sponsors translate scientific complexity into clear, regulatory compliant documentation and executable trial plans.

📘 Explore the full insights:
👉 https://tinyurl.com/4un7p594

📩 Looking to accelerate your rare disease clinical trial?
Connect with our experts:
👉 https://credevo.com/contact

31/12/2025

Wishing you a New Year filled with good health, calm days, and work that feels meaningful. 🎉💫

May there be kindness in your interactions, ease in your routine, and moments that make you pause and smile.🌟

Here’s to hope, warmth, and a beautiful year ahead 🥂

31/12/2025

🧬 Rare vs. Standard Clinical Trials: One Size Doesn’t Fit All

Effective clinical trials combine protocol adherence with strategies customised for the patient population. What works for common conditions often falls short in rare disease trials, where small, dispersed populations and unmet medical needs demand a different approach.

💡 The challenge:
Sponsors and CROs frequently face delays and feasibility issues when moving between standard and rare disease studies due to differences in trial design, recruitment, endpoints, and regulatory pathways.

✅ The solution: tailored clinical trial expertise
At Credevo, we help sponsors and CROs develop trial strategies that align with disease complexity, patient needs, and regulatory requirements, whether it’s a large-scale study or a rare disease trial.

📌 In our latest article, we cover:
✔️ Key differences in trial design, recruitment, and endpoints
✔️ Regulatory and market access considerations
✔️ Best practices to improve feasibility and ex*****on
✔️ Emerging trends shaping the future of clinical research

🔍 The right strategy can accelerate timelines, optimise outcomes, and improve patient access.

📘 Read the full article:
👉 https://tinyurl.com/5n8b56hf

🤝 Need expert support for your clinical trial strategy or ex*****on?
📩 Connect with us: https://credevo.com/contact

30/12/2025

🚚 Early-Phase Clinical Trials Move Faster with the Right Global Logistics Strategy

In early-phase and multi-regional clinical trials, time-sensitive shipments of medical devices, IMPs, and ancillary supplies can make or break study timelines. With varying customs and regulatory requirements across countries, global logistics quickly become a critical success factor.

💡 That’s where Importer of Record (IOR) and Exporter of Record (EOR) expertise adds real value.

Early engagement with IOR/EOR partners helps sponsors and CROs:
✅ Prevent customs delays and rework
✅ Stay compliant with country-specific regulations
✅ Align documentation, accountability, and risk across regions
✅ Enable faster site activation and uninterrupted trial ex*****on

🔍 In our latest article, we explore:
• Why early shipment planning is essential in early-phase trials
• The role of IOR/EOR in managing customs, licenses, and permits
• Country-specific challenges (Japan, China, Switzerland)
• Best practices for compliance, documentation, and risk control

📘 Read the full article for deeper insights:
👉 https://tinyurl.com/476s6dpp

🤝 Need support with global clinical trial logistics or regulatory documentation?
Our experts help sponsors and CROs navigate IOR/EOR complexities with confidence.

📩 Connect with us:
👉 https://credevo.com/contact

29/12/2025

✨ Strong SOPs Power High-Quality Clinical Trials

Behind every successful clinical trial is a foundation of clear, consistent Standard Operating Procedures (SOPs). When SOPs are well written and well implemented, they drive compliance, protect participants, and ensure data you can trust.

📋 SOPs are more than documentation; they are your quality system.
They help clinical research sites:
🔹 Standardise daily operations
🔹 Align with ICH-GCP, FDA (21 CFR), and IRB requirements
🔹 Minimise deviations and inspection findings
🔹 Stay audit-ready at every stage of the trial

🧠 This is where expert medical writing matters.
At Credevo, we develop regulator-aligned, site-specific SOPs that translate complex regulatory expectations into practical, usable procedures for your teams.

🔍 In our latest guide, we cover:
✔️ 10 essential SOPs every clinical research site should have
✔️ Key elements regulators expect to see
✔️ How SOPs support consistency, compliance, and trial success

📘 Read the full guide:
👉 https://tinyurl.com/nhbevcz9

💼 Need support with SOP development or updates?
Our medical writing experts are here to help you build SOPs that stand up to audits and support trial excellence.

📞 Get in touch:
👉 https://credevo.com/contact

26/12/2025

🇺🇸 Planning to Run Clinical Trials in the USA? Avoid Common Pitfalls and Get It Right

The U.S. is a global hub for clinical research, but navigating FDA regulations, trial setup, and supply imports can be complex without the right guidance.

🔎 In our latest guide, discover:
✅ The top advantages of running trials in the U.S.
✅ A clear, step-by-step approach to trial setup
✅ What you need to know about ClinicalTrials.gov registration
✅ FDA regulatory pathways and collaboration insights
✅ Practical tips for importing IMPs and ancillary supplies

Whether you are launching your first U.S. study or expanding your clinical footprint, this guide helps you move forward with confidence and compliance.

📘 Read the full article: https://tinyurl.com/mvt7bk48

Need expert support to plan, launch, or scale your U.S. clinical trial? Our team is here to help.
👉 https://credevo.com/contact

25/12/2025

🇦🇺 Looking for the Perfect Destination for Your Nutraceutical Clinical Trial?

Australia combines regulatory efficiency, world-class infrastructure, and research expertise, making it ideal for your next study.

🔍 In our latest article, learn how Australia offers:
✅ Fast, streamlined approvals via the CTN scheme
✅ Access to experienced investigators and modern facilities
✅ Generous R&D tax incentives
✅ High-quality data aligned with FDA and EMA standards
✅ A robust framework for complementary medicines

With a growing nutraceutical market and strong government support, Australia is ready to help you achieve your next clinical milestone.

🔗 Read more: https://tinyurl.com/366cf379

Need expert guidance planning your nutraceutical trial in Australia? Our team can help you navigate regulations, optimize design, and execute efficiently.
👉 https://credevo.com/contact

24/12/2025

⏱️ Avoid Costly Delays in Early-Phase Trials with Smart Shipment Planning

📦 Delays in getting medical devices, lab kits, or ancillary equipment on-site can derail timelines, increase costs, and trigger protocol amendments.

Early planning and the right IOR/EOR partner are key to staying on track.

In our latest guide, we cover:
✅ How early shipment planning prevents costly delays
✅ The critical role of IOR/ EOR in early-phase and MRCT logistics
✅ Country-specific challenges in Japan, China, and Switzerland
✅ Compliance tips for customs, documentation, and GxP standards

Ship smarter, stay compliant, and keep your trial on schedule.

🔗 Read more: https://tinyurl.com/4772msx9

Need expert guidance on clinical trial logistics across Japan? Our team can help you plan and execute efficiently.
👉 https://credevo.com/contact

23/12/2025

🚚 Planning a Clinical Trial in Japan? Don’t Let Ancillaries and Non-IMPs Hold You Back

Shipping lab kits, diagnostic devices, and other non-IMPs in Japan can be tricky. Strict customs rules and PMDA oversight mean even small mistakes can cause costly delays.

💡 Our latest guide covers:
✔️ Essential documentation and regulatory requirements
✔️ How IOR/EOR partners simplify import processes
✔️ Common mistakes and how to avoid them
✔️ Practical tips to keep your trial on track

Ensure smoother logistics, compliance, and faster trial progress with expert guidance.

🔗 Read more: https://tinyurl.com/2kcw93sy

Need hands-on support navigating trial logistics in Japan? Our experts can help you plan, manage, and execute efficiently.
👉 https://credevo.com/contact

22/12/2025

🔍 The Hidden Factor Behind Successful Clinical Trials

Clinical Trial Monitoring

Inconsistent monitoring leads to data gaps, protocol deviations, and delayed approvals. Sound familiar? You are not alone.

Strong monitoring is the foundation of patient safety, data integrity, and regulatory confidence. The right strategy turns oversight into a competitive advantage.

✅ Risk based and remote monitoring models
✅ Real time data verification and audit readiness
✅ Continuous safety surveillance
✅ Trained, aligned, and compliant study sites
✅ Technology driven oversight for faster decisions

When monitoring is done right, trials move faster with fewer surprises.

Looking to strengthen your clinical trial monitoring approach? Our experts can help you design, optimise, and execute with confidence.
👉 https://credevo.com/contact

19/12/2025

🔬 Rare vs. Standard Disease Trials: What's the Difference & Why It Matters? 💉

In the world of clinical research, understanding the challenges of rare vs. standard disease trials is essential. While both aim to improve patient care and advance medical science, the approach, design, and ex*****on vary greatly!

🔑 Key Differences:

Patient Recruitment: Rare disease trials face unique challenges due to limited patient pools. Standard trials have broader access, but more competition.

Trial Design: Rare trials often require adaptive designs or single-arm studies due to small sample sizes, while standard trials usually follow randomized controlled trials.

Market Impact: Rare disease treatments may offer high pricing potential, while standard trials target mass markets with more competitive pricing.

💡 Need expert guidance on navigating these complex trials and designing successful studies? Whether you're dealing with small patient populations or scaling for large-scale impact, we're here to help! 🌍

📲 Get in touch with us for tailored advice and solutions: 👉 https://credevo.com/contact

Address

Singapore

Website

https://credevo.com/

Alerts

Be the first to know and let us send you an email when Credevo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

The Prenatal Consultants
101 Irrawaddy Road, #15-05/06 Royal Square Medical Centre

Want your practice to be the top-listed Clinic in Singapore?

Credevo

02/01/2026

01/01/2026

31/12/2025

31/12/2025

30/12/2025

29/12/2025

26/12/2025

25/12/2025

24/12/2025

23/12/2025

22/12/2025

19/12/2025

Address

Website

Alerts

Shortcuts

Featured

Share

Category